Abstract
The emerging field of pharmacogenetics has the potential to advance the science of nicotine dependence treatment by generating new knowledge about genetic factors that influence therapeutic response. The basic premise of this approach is that inherited differences in drug metabolism and drug targets have important effects on treatment toxicity and efficacy. This chapter reviews evidence supporting the potential utility of a pharmacogenetic approach to the treatment of nicotine dependence. Future research directions and issues related to the clinical integration of genetic testing to tailor nicotine dependence treatment are also addressed.
| Original language | English |
|---|---|
| Title of host publication | Medication Treatments for Nicotine Dependence |
| Publisher | CRC Press |
| Chapter | 18 |
| Pages | 263-274 |
| Number of pages | 12 |
| ISBN (Electronic) | 9781420005431 |
| ISBN (Print) | 0849337798, 9780849337796 |
| DOIs | |
| Publication status | Published - 31 Jul 2006 |
Bibliographical note
Publisher Copyright:© 2007 by Taylor & Francis Group, LLC.
ASJC Scopus subject areas
- General Medicine
- General Pharmacology, Toxicology and Pharmaceutics
- General Neuroscience
Fingerprint
Dive into the research topics of 'Pharmacogenetic approaches to the treatment of nicotine dependence'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS